Anti-EGFR monoclonal antibody-Tc-99
Alternative Names: DiaCIM; DiaCIM h-R3Latest Information Update: 05 May 2004
Price :
$50 *
At a glance
- Originator CIMYM
- Class Monoclonal antibody diagnostics; Organotechnetium compounds; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 05 May 2004 Discontinued - Phase-I for Solid tumours (diagnosis) in Canada (unspecified route)
- 05 May 2004 Discontinued - Phase-I for Solid tumours (diagnosis) in Cuba (unspecified route)
- 28 Mar 2003 This compound is available for licensing (http://cim.sld.cu)